<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8005433</journal-id><journal-id journal-id-type="pubmed-jr-id">5723</journal-id><journal-id journal-id-type="nlm-ta">Med Sci Sports Exerc</journal-id><journal-id journal-id-type="iso-abbrev">Med Sci Sports Exerc</journal-id><journal-title-group><journal-title>Medicine and science in sports and exercise</journal-title></journal-title-group><issn pub-type="ppub">0195-9131</issn><issn pub-type="epub">1530-0315</issn></journal-meta><article-meta><article-id pub-id-type="pmid">28557860</article-id><article-id pub-id-type="pmc">7059860</article-id><article-id pub-id-type="doi">10.1249/MSS.0000000000001331</article-id><article-id pub-id-type="manuscript">HHSPA1557289</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Applying the ACSM Preparticipation Screening Algorithm to U.S. adults, NHANES 2001&#x02014;04</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Whitfield</surname><given-names>Geoffrey P</given-names></name><degrees>PhD Med</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Riebe</surname><given-names>Deborah</given-names></name><degrees>PhD MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Magal</surname><given-names>Meir</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Liguori</surname><given-names>Gary</given-names></name><degrees>PhD MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Centers for Disease Control and Prevention, Atlanta, GA</aff><aff id="A2"><label>2</label>University of Rhode Island, Kingston, RI</aff><aff id="A3"><label>3</label>North Carolina Wesleyan College, Rocky Mount, NC</aff><author-notes><corresp id="CR1">Corresponding Author: Geoffrey P Whitfield, Centers for Disease Control and Prevention, 4770 Buford Highway, MS F-77, Atlanta, GA 30341, 770-488-3976 (v); 770-488-4820 (f), <email>xdh5@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>06</day><month>3</month><year>2020</year></pub-date><volume>49</volume><issue>10</issue><fpage>2056</fpage><lpage>2063</lpage><!--elocation-id from pubmed: 10.1249/MSS.0000000000001331--><abstract id="ABS1"><sec id="S1"><title>PURPOSE:</title><p id="P1">For most people, the benefits of physical activity far outweigh the risks. Research has suggested exercise preparticipation questionnaires might refer an unwarranted number of adults for medical evaluation before exercise initiation, creating a potential barrier to adoption. The new American College of Sports Medicine (ACSM) prescreening algorithm relies on current exercise participation; history and symptoms of cardiovascular, metabolic or renal disease; and desired exercise intensity to determine referral status. Our purpose was to compare the referral proportion of the ACSM algorithm to that of previous screening tools using a representative sample of US adults.</p></sec><sec id="S2"><title>METHODS:</title><p id="P2">Based on responses to health questionnaires from the 2001&#x02013;2004 National Health and Nutrition Examination Survey, we calculated the proportion of adults aged 40 years or older who would be referred for medical clearance before exercise participation based on the ACSM algorithm. Results were stratified by age and sex and compared to previous results for the ACSM/American Heart Association Preparticipation Questionnaire and the Physical Activity Readiness Questionnaire.</p></sec><sec id="S3"><title>RESULTS:</title><p id="P3">Based on the ACSM algorithm, 2.6% of adults would be referred only before beginning vigorous exercise and 54.2% of respondents would be referred before beginning any exercise. Men were more frequently referred before vigorous exercise and women were more frequently referred before any exercise. Referral was more common with increasing age. The ACSM algorithm referred a smaller proportion of adults for preparticipation medical clearance than the previously examined questionnaires.</p></sec><sec id="S4"><title>CONCLUSIONS:</title><p id="P4">Although additional validation is needed to determine if the algorithm correctly identifies those at risk for cardiovascular complications, the revised ACSM algorithm referred fewer respondents than other screening tools. A lower referral proportion may mitigate an important barrier of medical clearance from exercise participation.</p></sec></abstract><kwd-group><kwd>Population</kwd><kwd>Exercise safety</kwd><kwd>Cardiovascular screening</kwd><kwd>physician exam</kwd></kwd-group></article-meta></front><body><sec id="S5"><title>Introduction</title><p id="P5">The benefits of regular participation in physical activity are well-established and consistently outweigh the risks of participation (<xref rid="R10" ref-type="bibr">10</xref>). Musculoskeletal injuries are the most common adverse event associated with physical activity participation, and are seldom severe (<xref rid="R10" ref-type="bibr">10</xref>). An individual bout of activity also carries an elevated risk of acute myocardial infarction (AMI) or sudden cardiac death (SCD). While severe, these events are rare and most commonly occur among habitually inactive people performing vigorous-intensity activity (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R10" ref-type="bibr">10</xref>); the risk of AMI or SCD during activity is sharply attenuated by progressive, regular physical activity participation (<xref rid="R10" ref-type="bibr">10</xref>). Among adults, occlusive coronary artery disease is usually the underlying cause of activity-associated AMI and SCD (<xref rid="R7" ref-type="bibr">7</xref>). Because of this, attempts to identify adults at risk for activity associated AMI or SCD have often included cardiovascular disease (CVD) risk factor assessment (<xref rid="R1" ref-type="bibr">1</xref>).</p><p id="P6">The American College of Sports Medicine (ACSM) recently released an updated exercise preparticipation screening algorithm (henceforth: ACSM algorithm) that focuses on 1) the respondent&#x02019;s current exercise participation 2) the presence of signs/symptoms or known history of cardiovascular diseases and 3) the desired exercise intensity, and in contrast to previous screening tools, does not assess cardiovascular risk factors (<xref rid="R11" ref-type="bibr">11</xref>). These changes came about in part because of indications that CVD risk factor-based screening may be overly conservative and unnecessarily refer adults for medical clearance before exercise participation (<xref rid="R15" ref-type="bibr">15</xref>). Using data from the 2001&#x02013;2004 National Health and Nutrition Examination Survey (NHANES), the ACSM/American Heart Association Preparticipation Questionnaire (AAPQ) could potentially refer 95% of all US adults aged 40 years or older to a medical provider before beginning an exercise program (<xref rid="R15" ref-type="bibr">15</xref>), and 68% of US adults aged 40 years or older could be referred using the Physical Activity Readiness Questionnaire (PAR-Q) (<xref rid="R15" ref-type="bibr">15</xref>).</p><p id="P7">Additionally, The AAPQ and PAR-Q predate the 2008 Physical Activity Guidelines for Americans, which, like the ACSM algorithm, focus not on CVD risk factors, but on history of chronic diseases, the symptoms thereof, and current activity levels to inform the need for medical involvement (<xref rid="R13" ref-type="bibr">13</xref>). To date, referral estimates for the new ACSM algorithm are not available, so its performance relative to the AAPQ and PAR-Q is unknown. Therefore, the purpose of this research was to estimate the proportion of US adults aged 40 years or older that would be referred for preparticipation medical clearance using the ACSM algorithm in order to place this tool in context with previous findings.</p></sec><sec id="S6"><title>Methods</title><sec id="S7"><title>Data Source</title><p id="P8">To ensure comparability across the three screening measures, a dataset from previous work was used that included health history interview responses from US adults aged 40 years or older from the 2001&#x02013;2004 NHANES (<xref rid="R15" ref-type="bibr">15</xref>). Accordingly, the number of respondents and demographic characteristics of the samples are identical with the previous report (<xref rid="R15" ref-type="bibr">15</xref>). This dataset was limited to adults aged 40 years and older because of 1) the importance of underlying CVD as a causative factor for exercise-associated SCD and MI in adults and 2) age restrictions in many of the CVD questionnaire items in the data source. Complete information regarding NHANES methods are publically available from the Centers for Disease Control and Prevention (<xref rid="R9" ref-type="bibr">9</xref>) and are only summarized here. NHANES is an ongoing public health surveillance system that uses multistaged, stratified, probability sampling methods to achieve a representative sample of the US, non-institutionalized population. Among all individuals screened to participate, 84% in 2001&#x02013;2002 and 79% in 2003&#x02013;2004 completed questionnaires (<xref rid="R9" ref-type="bibr">9</xref>). Data are continuously collected and are prepared for release every two years. All NHANES data collection activities are approved by the research ethics review board of the National Center for Health Statistics and include informed consent for all participants.</p></sec><sec id="S8"><title>Referral for medical clearance</title><p id="P9">The ACSM algorithm (<xref rid="F1" ref-type="fig">Figure 1</xref>) first classifies respondents as active or inactive based on the presence or absence of exercise in the past 3 months, with exercise defined as planned, structured physical activity at least 30 min at moderate intensity on at least 3 days per week. Next, respondents are classified based on presence or absence of known cardiovascular, metabolic, or renal disease and presence or absence of signs or symptoms of these conditions (<xref rid="F1" ref-type="fig">Figure 1</xref>, footnote). Recommendations for medical clearance are then made based on the desired intensity of exercise:</p><list list-type="bullet" id="L2"><list-item><p id="P10">Among those not currently exercising:
<list list-type="bullet" id="L4"><list-item><p id="P11">Asymptomatic respondents with no history of the specified diseases are recommended to begin light to moderate intensity physical exercise without clearance, and gradually progress per ACSM guidelines</p></list-item><list-item><p id="P12">Asymptomatic respondents with a positive history of the specified diseases are recommended to seek medical clearance before beginning exercise of any intensity</p></list-item><list-item><p id="P13">Symptomatic respondents, regardless of history, are recommended to seek medical clearance before beginning exercise of any intensity</p></list-item></list></p></list-item><list-item><p id="P14">Among those currently exercising:
<list list-type="bullet" id="L6"><list-item><p id="P15">Asymptomatic respondents with no history of the specified diseases are encouraged to continue moderate or vigorous intensity exercise without clearance, and gradually progress per ACSM guidelines</p></list-item><list-item><p id="P16">Asymptomatic respondents with a positive history of the specified diseases are encouraged to continue light to moderate intensity exercise without clearance, but should have medical clearance before progressing to vigorous intensity exercise</p></list-item><list-item><p id="P17">Symptomatic respondents, regardless of history, are recommended to seek medical clearance before continuing exercise of any intensity</p></list-item></list></p></list-item></list></sec><sec id="S9"><title>Linking NHANES to the ACSM Algorithm, AAPQ, and PAR-Q</title><p id="P18">The health questionnaires from NHANES 2001&#x02013;2004 provide much of the information needed to complete the ACSM algorithm. A matrix of algorithm components and their corresponding NHANES items is presented in <xref rid="T1" ref-type="table">Table 1</xref>. To determine current exercise participation (based on the algorithm&#x02019;s definition noted previously), the weekly frequency of each selected leisure activity (bouts per week) was estimated by dividing reported monthly frequency by 4.286. The weekly frequency was then multiplied by the reported duration (minutes per bout) and NHANES-assigned metabolic equivalent value (METs), which is a measure of exercise intensity. This provided estimated weekly exercise volume in MET*minutes/week. A value of &#x02265;270 MET*minutes/week was classified as current regular exercise (30 minutes * 3 times per week * &#x02265;3 METs). Several items in the ACSM algorithm were not available in NHANES. Regarding CVD history, we were unable to determine if respondents had a previous diagnosis of peripheral vascular disease, but patients could report pain in the lower legs when walking, which may capture intermittent claudication. Regarding signs and symptoms of CVD, we were unable to ascertain presence of orthopnea or paroxysmal nocturnal dyspnea (PND), ankle edema, palpitations or tachycardia, murmur, or unusual fatigue. Sensitivity analyses suggested that signs and symptoms we were able to assess tended to occur jointly (few reported only one symptom). For example, of the 816 respondents that reported chest pain, fully 88% reported &#x02265;1 additional assessed symptom; of the 2,478 that reported breathlessness, 60% reported &#x02265;1 additional symptom. Three of five omitted symptoms relate to heart failure (orthopnea and PND, ankle edema, and unusual fatigue) and often cluster together (<xref rid="R14" ref-type="bibr">14</xref>), which would lessen the impact of each symptom&#x02019;s omission.</p><p id="P19">For each participant, binary variables for each component of the ACSM algorithm were created. The value of this variable was determined by the value of the corresponding NHANES item(s) (<xref rid="T1" ref-type="table">Table 1</xref>). These binary variables were used to classify respondents into the six possible groups in the algorithm. Next, the referral status based on algorithm classification was assigned: 1) no clearance needed, 2) clearance needed before vigorous-intensity exercise only, and 3) clearance needed before any exercise. As noted previously (<xref rid="R15" ref-type="bibr">15</xref>), this method of algorithm completion and scoring operates under the assumption that respondents will answer a preparticipation questionnaire in the same manner that they answer the health history items in NHANES.</p><p id="P20">A similar process was used to complete the AAPQ and PAR-Q based on NHANES responses. These methods have been previously published (<xref rid="R15" ref-type="bibr">15</xref>) and are only summarized here. Following the AAPQ instructions, a participant was classified as referred if he or she responded &#x02018;yes&#x02019; to any of the history and symptoms of CVD items or &#x0201c;other health issues&#x0201d; items, or responded yes to two or more CVD Risk factor items (see Table, <xref rid="SD2" ref-type="supplementary-material">SDC 1</xref>, Items from the AAPQ and their corresponding items from NHANES 2001&#x02013;2004). Following the PAR-Q instructions, a respondent was classified as referred if he or she were aged &#x0003e;69 years and reported less than the equivalent of 10 minutes per day of combined transportation, household/occupational, or leisure time physical activity of at least moderate intensity, or responded &#x02018;yes&#x02019; to any of the PAR-Q items for which NHANES corollaries were available (see Table, <xref rid="SD1" ref-type="supplementary-material">SDC 2</xref>, PAR-Q items and their corresponding items from NHANES 2001&#x02013;2004).</p></sec><sec id="S10"><title>Statistical Analyses</title><p id="P21">Referral proportions with 95% confidence intervals were calculated for the sample as a whole, and stratified by sex and age group. A cross-tabulation of referral status comparing the ACSM algorithm to the AAPQ and PAR-Q was also conducted. Differences in referral proportions were assessed with Wald tests with a Bonferroni correction for multiple comparisons; &#x003b1;=0.5.</p><p id="P22">Post-hoc analyses were done to investigate the prevalence of reported symptoms of CVD. A Monte Carlo simulation was conducted to determine the sensitivity of the algorithm to the most prevalent symptom. In 500 replications, 10% of those reporting &#x02018;no&#x02019; for the most prevalent symptom were randomly reassigned to &#x02018;yes&#x02019; and the referral criteria were applied to the resulting dataset. This process was also used to change 10% of those originally reporting &#x02018;yes&#x02019; for the most prevalent symptom to &#x02018;no&#x02019;. The average of the 500 referral proportions under each condition (10% higher and 10% lower prevalence) was then compared to the original referral proportions. All analyses used sampling and analytic weights supplied by NHANES. Variance estimation was by Taylor series linearization. Survey commands within Stata version 13.1 were used for all analyses.</p></sec></sec><sec id="S11"><title>Results</title><p id="P23">The descriptive characteristics for this sample have been previously described (<xref rid="R15" ref-type="bibr">15</xref>) and are summarized here. Complete questionnaire responses were available for 3459 women (97.9% of total) and 3326 men (98.5% of total), accordingly, the demographic characteristics were quite similar to the general adult population over 40 years of age in the US from this time period. Based on the algorithm definition above, 47.1% reported enough leisure time activity to be classified as current exercisers.</p><p id="P24">The distribution of the population across the six categories of the 2015 ACSM algorithm and the total referral proportions are presented in <xref rid="T2" ref-type="table">Table 2</xref>. Among those reporting no current exercise, 18.0% reported no history or current symptoms, 3.0% reported a positive history but no current symptoms, and 32.0% reported current symptoms. Among those currently exercising, 25.1% reported no history or current symptoms, 2.6% reported a positive history but no current symptoms, and 19.3% reported current symptoms. With this distribution across categories, 43.1% of the population would receive no referral for medical clearance before beginning or continuing exercise, 2.6% would be referred for medical clearance before engaging in vigorous intensity exercise, and 54.2% would be referred for medical clearance before beginning or continuing any exercise.</p><p id="P25">The referral proportions stratified by sex and age group are presented in <xref rid="T3" ref-type="table">Table 3</xref>. Across four of the seven age groups and for the sample as a whole, women would be referred for medical clearance before any exercise more frequently than men (all p&#x0003c;0.05). The differences between men and women across age groups was less clear for referral before vigorous intensity exercise, but no group exceeded a 7% referral proportion for this outcome.</p><p id="P26">Combined results from the ACSM algorithm, the AAPQ, and the PAR-Q are presented in <xref rid="F2" ref-type="fig">Figure 2</xref>, stratified by age group. Across all age groups, the AAPQ would refer more respondents (94.5%) than either the PAR-Q (68.4%) or the ACSM algorithm, including those referred only before vigorous exercise (2.6%) and those referred before any exercise (54.2%). When considering those referred before any exercise, the ACSM algorithm and the PAR-Q performed similarly in the 40&#x02013;44 year age group (42.9% and 48.8% referred, respectively), then the referral proportions diverged with increasing age. For those aged 70 years or older, the ACSM algorithm would refer 70.9% before any exercise and the PAR-Q would refer 93.2%.</p><p id="P27">According to the cross-tabulation presented in <xref rid="T4" ref-type="table">Table 4</xref>, 37.7% of respondents were referred by the AAPQ but were not referred by the ACSM algorithm. Only one respondent (&#x0003c;0.1% of the weighted total) was not referred based on the AAPQ but was referred before vigorous-intensity exercise based on the ACSM algorithm. Further, 19.0% of respondents were referred based on the PAR-Q but were not referred based on the ACSM algorithm. Only 7.4% of respondents were not referred based on the PAR-Q but were referred based on the ACSM algorithm (0.5% before vigorous-intensity exercise only, 6.9% before any exercise).</p><p id="P28">The proportion that reported any current symptoms was higher than expected (54.2%) and further investigated. Shortness of breath was the most commonly reported symptom: 72.0% of those with any symptom reported shortness of breath. It is likely that many reported cases of shortness of breath are due to benign causes other than worsening CVD. Monte Carlo-based sensitivity analyses suggested shortness of breath was an important referral trigger. When the prevalence of shortness of breath was randomly increased 10% in the sample, the proportion referred for clearance before any exercise increased 9% (five percentage points) from 54% to 59%. When the prevalence was decreased by 10%, the proportion referred before any exercise decreased 2% (one percentage point) to 53% (not shown).</p></sec><sec id="S12"><title>Discussion</title><p id="P29">Using the same methods and assumptions as a previous evaluation (<xref rid="R15" ref-type="bibr">15</xref>), the ACSM algorithm would refer fewer US adults aged 40 years or older for medical clearance than either the AAPQ or the PAR-Q. Previous research suggested that 95% of this demographic group would be referred for a physician visit under the AAPQ scoring criteria. While additional validation is needed, this analysis suggests 37.7% of adults in this age range that would be referred based on the AAPQ would not be referred based on the ACSM algorithm. This reduction in referrals may mitigate a potentially important barrier to exercise adoption.</p><p id="P30">The lower referral proportion in the ACSM algorithm is likely attributable to the removal of CVD risk factors from the prescreening criteria. Because of the widespread prevalence of CVD risk factors (<xref rid="R4" ref-type="bibr">4</xref>) and the rarity of exercise-associated CVD events (<xref rid="R12" ref-type="bibr">12</xref>), CVD risk factor assessment is likely a poor predictor of these events. For example, the CDC estimates that 70 million American adults have high blood pressure, compared to 600,000 who die of CVD each year (0.9% of 70 million) (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>), and only a small percent of these CVD deaths occur during exercise (<xref rid="R12" ref-type="bibr">12</xref>). Assessment of CVD risk factors therefore may overestimate the proportion of people at risk for exercise-associated CVD complications. The removal of CVD risk factors also aligns the ACSM algorithm with the 2008 Physical Activity Guidelines for Americans, which place focus on diagnosed chronic diseases and symptoms thereof:</p><disp-quote id="Q1"><p id="P31">&#x0201c;People without diagnosed chronic conditions (such as diabetes, heart disease, or osteoarthritis) and who do not have symptoms (such as chest pain or pressure, dizziness, or joint pain) do not need to consult a health-care provider about physical activity.&#x0201d; (<xref rid="R13" ref-type="bibr">13</xref>)</p></disp-quote><p id="P32">As with the ACSM algorithm, the Guidelines also consider a person&#x02019;s initial level of activity, progression of activity, and development of symptoms when considering medical involvement:</p><disp-quote id="Q2"><p id="P33">&#x0201c;Inactive people who gradually progress over time to relatively moderate-intensity activity have no known risk of sudden cardiac events, and very low risk of bone, muscle, or joint injuries. A person who is habitually active with moderate-intensity activity can gradually increase to vigorous intensity without needing to consult a health-care provider. People who develop new symptoms when increasing their levels of activity should consult a health-care provider.&#x0201d; (<xref rid="R13" ref-type="bibr">13</xref>)</p></disp-quote><p id="P34">While designed primarily for fitness professionals, the ACSM algorithm is more aligned with the public health recommendations set forth in the Physical Activity Guidelines than previous screening tools.</p><p id="P35">The ACSM algorithm differentiates referrals based on the desired exercise intensity of the respondent, and the proportion that would be referred before any exercise was much higher than the proportion that would be referred only before vigorous intensity exercise. This is likely attributed to two factors. First, a recommendation for clearance only before vigorous exercise is given to one highly specific group in the algorithm: those who have previously had cardiovascular, metabolic, or renal disease, but have recovered or stabilized to the point that they now perform regular exercise and are free of symptoms. They warrant referral under the algorithm only before increasing to vigorous intensity. Second, in contrast to the very specific group previously mentioned, three of the six categories in the algorithm receive a recommendation for clearance before any exercise. These include any respondents that report a current symptom (both physically active and inactive) and those that are currently inactive and have a history of cardiovascular, metabolic, or renal disease. Among adults aged 40 years and older, this includes a considerable proportion of the population. Samples with more diverse age ranges would likely exhibit different referral proportions.</p><p id="P36">Using the present methods, the referral proportion of the ACSM algorithm was more similar to the PAR-Q than the AAPQ, which was likely because of the similarity of these two instruments. For example, both the ACSM algorithm and PAR-Q place emphasis on a history of CVD, current chest pain, and dizziness or lack of balance. Further, the ACSM algorithm does not consider age and the PAR-Q only considers age as important if the person is currently inactive. The 19.0% of respondents that were referred based on the PAR-Q but not referred based on the ACSM algorithm is likely due to the inclusion of bone and joint issues and medication use for hypertension in the PAR-Q, neither of which are considered in the ACSM algorithm.</p><p id="P37">This report has several strengths. First, the exact methods and dataset from a previous evaluation of the AAPQ and PAR-Q were used, allowing comparison of referral proportions under identical assumptions (<xref rid="R15" ref-type="bibr">15</xref>). Second, the NHANES dataset is representative of the non-institutionalized US population over 40 years of age; this study provides information about referral performance in the general public. Finally, this method allows for rapid comparison of screening tools at low cost. Several limitations should also be noted. First, several symptoms on the ACSM algorithm could not be assessed, but analyses suggested that assessed symptoms tended to cluster together, which could limit the impact of unassessed symptoms. Nevertheless, omission of symptoms could cause an underestimation of referral proportion. Second, we were unable to assess referral proportions in adults under 40 years of age. Third, as with the previous report (<xref rid="R15" ref-type="bibr">15</xref>), this method assumes that people will answer a pre-screening questionnaire the same way they answered comprehensive health interview questions, and the validity of this assumption is unknown. Finally, the criteria for participating in regular exercise in the ACSM algorithm is different from the 2008 Physical Activity Guidelines (<xref rid="R13" ref-type="bibr">13</xref>), but a post-hoc analysis that defined regular exercise as 150 minutes per week of at least moderate intensity leisure-time activity instead of 90 minutes per week suggested little impact on referral status (43.1% not referred [43.1% originally], 2.3% referred before vigorous exercise [2.6% originally], and 54.6% referred before any exercise [54.2% originally]).</p><p id="P38">In conclusion, the revised ACSM algorithm referred fewer NHANES respondents for medical clearance compared to the AAPQ. Definitive confirmation of this finding would require comparison of referral proportions in actual practice in exercise facilities. While additional validation is needed to determine how well the algorithm identifies those at risk for CVD complications during exercise, a lower referral proportion may mitigate an important barrier to exercise adoption, especially among those who undergo a preparticipation screening program based on ACSM recommendations. Considering that 73% of ACSM-certified Health Fitness Specialists report performing some type of preparticipation screening (<xref rid="R2" ref-type="bibr">2</xref>), the potential use of this new algorithm is considerable.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>SupplTable2</label><caption><p id="P39">SDC 2: Table: PAR-Q items and their corresponding items from NHANES 2001&#x02013;2004</p></caption><media xlink:href="NIHMS1557289-supplement-SupplTable2.docx" orientation="portrait" id="d36e388" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>SupplTable1</label><caption><p id="P40">SDC 1: Table: Items from the AAPQ and their corresponding items from NHANES 2001&#x02013;2004</p></caption><media xlink:href="NIHMS1557289-supplement-SupplTable1.docx" orientation="portrait" id="d36e395" position="anchor"/></supplementary-material></sec></body><back><ack id="S13"><title>Acknowledgements</title><p id="P41">No outside funds were used for this study. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.</p></ack><fn-group><fn id="FN1"><p id="P42" content-type="publisher-disclaimer">Disclaimer</p><p id="P43" content-type="publisher-disclaimer">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, nor do they constitute endorsement by ACSM.</p></fn><fn fn-type="COI-statement" id="FN3"><p id="P44">Conflict of Interest</p><p id="P45">The authors have participated in development of the ACSM preparticipation screening algorithm and the Guidelines for Exercise Testing and Prescription. Other than travel compensation, no financial support was received.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="book"><collab>American College of Sports Medicine</collab>. <chapter-title>Preparticipation Health Screening</chapter-title> In: <name><surname>Pescatello LS Arena</surname><given-names>R</given-names></name>, <name><surname>Riebe</surname><given-names>D</given-names></name>, <name><surname>Thompson</surname><given-names>P</given-names></name>, editors. <source>ACSM&#x02019;s guidelines for exercise testing and prescription</source>. <edition>9th ed</edition>
<publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name>; <year>2014</year> p. <fpage>23</fpage>&#x02013;<lpage>31</lpage>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Craig</surname><given-names>AC</given-names></name>, <name><surname>Eickhoff-Shemek</surname><given-names>J</given-names></name>. <article-title>Adherence to ACSM&#x02019;s Pre-Activity Screening Procedures in Fitness Facilities: a National Investigation</article-title>. <source>J Phys Ed Sports Mgmt</source>. <year>2015</year>;<volume>2</volume>(<issue>2</issue>):<fpage>120</fpage>&#x02013;<lpage>137</lpage>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Dahabreh</surname><given-names>IJ</given-names></name>, <name><surname>Paulus</surname><given-names>JK</given-names></name>. <article-title>Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis</article-title>. <source>JAMA</source>. <year>2011</year>;<volume>305</volume>:<fpage>1225</fpage>&#x02013;<lpage>1233</lpage>.<pub-id pub-id-type="pmid">21427375</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="book"><source>Heart Disease Risk Factors [Internet]</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; [<comment>Cited</comment>
<date-in-citation>2016 December 1</date-in-citation>]. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/heartdisease/risk_factors.htm">http://www.cdc.gov/heartdisease/risk_factors.htm</ext-link>.</comment></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="book"><source>Heart Disease Statistics and Maps [Internet]</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; [<comment>Cited</comment>
<date-in-citation>27 October 2016</date-in-citation>]. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/heartdisease/statistics_maps.htm">http://www.cdc.gov/heartdisease/statistics_maps.htm</ext-link>.</comment></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="book"><source>High Blood Pressure [Internet]</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; [<comment>Cited</comment>
<date-in-citation>27 October 2016</date-in-citation>]. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/bloodpressure/index.htm">http://www.cdc.gov/bloodpressure/index.htm</ext-link>.</comment></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Kohl</surname><given-names>HW</given-names><suffix>3rd</suffix></name>, <name><surname>Powell</surname><given-names>KE</given-names></name>, <name><surname>Gordon</surname><given-names>NF</given-names></name>, <name><surname>Blair</surname><given-names>SN</given-names></name>, <name><surname>Paffenbarger</surname><given-names>RS</given-names><suffix>Jr.</suffix></name>
<article-title>Physical activity, phyical fitness, and sudden cardiac death</article-title>. <source>Epidemiol Rev</source>. <year>1992</year>;<volume>14</volume>:<fpage>37</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">1289116</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Mittleman</surname><given-names>MA</given-names></name>, <name><surname>Maclure</surname><given-names>M</given-names></name>, <name><surname>Tofler</surname><given-names>GH</given-names></name>, <name><surname>Sherwood</surname><given-names>JB</given-names></name>, <name><surname>Goldberg</surname><given-names>RJ</given-names></name>, <name><surname>Muller</surname><given-names>JE</given-names></name>. <article-title>Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators</article-title>. <source>N Engl J Med</source>. <year>1993</year>;<volume>329</volume>(<issue>23</issue>):<fpage>1677</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">8232456</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="book"><source>National Health and Nutrition Examination Survey; Questionnaires, Datasets, and Related Documentation [Internet]</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; [<comment>Cited</comment>
<date-in-citation>27 October 2016</date-in-citation>]. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm">http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm</ext-link>.</comment></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="book"><chapter-title>Physical Activity Guidelines Advisory Committee</chapter-title>
<source>Physical Activity Guidelines Advisory Committee Report</source>. <year>2008</year>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services</publisher-name>; <comment>2008.</comment></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Riebe</surname><given-names>D</given-names></name>, <name><surname>Franklin</surname><given-names>BA</given-names></name>, <name><surname>Thompson</surname><given-names>PD</given-names></name>, <name><surname>Garber</surname><given-names>CE</given-names></name>, <name><surname>Whitfield</surname><given-names>GP</given-names></name>, <name><surname>Magal</surname><given-names>M</given-names></name>, <name><surname>Pescatello</surname><given-names>LS</given-names></name>. <article-title>Updating ACSM&#x02019;s Recommendations for Exercise Preparticipation Health Screening</article-title>. <source>Med Sci Sports Exerc</source>. <year>2015</year>;<volume>47</volume>(<issue>11</issue>):<fpage>2473</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26473759</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>PD</given-names></name>, <name><surname>Franklin</surname><given-names>BA</given-names></name>, <name><surname>Balady</surname><given-names>GJ</given-names></name>, <etal/>
<article-title>Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>115</volume>(<issue>17</issue>):<fpage>2358</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">17468391</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="book"><chapter-title>United States Department of Health and Human Services</chapter-title>
<source>Physical Activity Guidelines for Americans, Chapter 6: Safe and Active</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services</publisher-name>; <year>2008</year> Pgs <fpage>35</fpage>&#x02013;<lpage>40</lpage>. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="https://health.gov/paguidelines/guidelines/chapter6.aspx">https://health.gov/paguidelines/guidelines/chapter6.aspx</ext-link>.</comment> [<comment>Cited</comment>
<date-in-citation>20 December 2016</date-in-citation>].</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="book"><source>Warning Signs of Heart Failure [Internet]</source>. <publisher-loc>Dallas, TX</publisher-loc>: <publisher-name>American Heart Association</publisher-name>; [<comment>Cited</comment>: <date-in-citation>11 May 2017</date-in-citation>]. <comment>Available from</comment>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.heart.org/HEARTORG/Conditions/HeartFailure/WarningSignsforHeartFailure/Warning-Signs-of-Heart-Failure_UCM_002045_Article.jsp#.WRSrCU1dBD8">http://www.heart.org/HEARTORG/Conditions/HeartFailure/WarningSignsforHeartFailure/Warning-Signs-of-Heart-Failure_UCM_002045_Article.jsp#.WRSrCU1dBD8</ext-link>.</comment></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Whitfield</surname><given-names>GP</given-names></name>, <name><surname>Pettee Gabriel</surname><given-names>KK</given-names></name>, <name><surname>Rahbar</surname><given-names>MH</given-names></name>, <name><surname>Kohl</surname><given-names>HW</given-names><suffix>3rd</suffix></name>. <article-title>Application of the American Heart Association/American College of Sports Medicine Adult Preparticipation Screening Checklist to a nationally representative sample of US adults aged &#x0003e;=40 years from the National Health and Nutrition Examination Survey 2001 to 2004</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>129</volume>(<issue>10</issue>):<fpage>1113</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">24421370</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1:</label><caption><title>2015 ACSM Preparticipation Screening Algorithm, reproduced with permission from Riebe, et al (<xref rid="R11" ref-type="bibr">11</xref>)</title><p id="P47"><sup><bold>&#x000a7;</bold></sup><bold>Exercise Participation</bold> Performing planned, structured physical activity at least 30 min at moderate intensity on at least 3 d&#x02219;wk<sup>&#x02212;1</sup> for at least the last 3 months.</p><p id="P48"><bold>*Light Intensity Exercise</bold>: 30% to &#x0003c;40% HRR or VO<sub>2</sub>R, 2 to &#x0003c;3 METs, 9&#x02013;11 RPE, an intensity that causes slight increases in HR and breathing</p><p id="P49"><bold>**Moderate Intensity Exercise</bold> 40% to &#x0003c;60% HRR or VO<sub>2</sub>R, 3 to &#x0003c;6 METs, 12&#x02013;13 RPE, an intensity that causes noticeable increases in HR and breathing</p><p id="P50"><bold>***Vigorous Intensity Exercise</bold> &#x02265;60% HRR or VO<sub>2</sub>R, &#x02265;6 METs, &#x02265;14 RPE, an intensity that causes substantial increases in HR and breathing</p><p id="P51"><sup>&#x02021;</sup>
<bold>Cardiovascular (CV) Disease</bold> Cardiac, peripheral vascular, or cerebrovascular disease.</p><p id="P52"><sup>&#x02021;&#x02021;</sup><bold>Metabolic Disease</bold> Type 1 and 2 diabetes mellitus.</p><p id="P53"><sup>&#x02021;&#x02021;&#x02021;</sup><bold>Signs and Symptoms</bold> At rest or during activity; includes pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication; known heart murmur; or unusual fatigue or shortness of breath with usual activities.</p><p id="P54"><sup>&#x02021;&#x02021;&#x02021;&#x02021;</sup><bold>Medical Clearance</bold> Approval from a healthcare professional to engage in exercise.</p><p id="P55"><sup>&#x00278;</sup><bold>ACSM Guidelines</bold> See ACSM&#x02019;s Guidelines for Exercise Testing and Prescription, 9<sup>th</sup> edition, 2014</p></caption><graphic xlink:href="nihms-1557289-f0001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2:</label><caption><title>Comparison of predicted referral proportions for the 2015 ACSM algorithm, AAPQ, and PAR-Q</title><p id="P57">Results for the AAPQ and PAR-Q have been previously published (<xref rid="R15" ref-type="bibr">15</xref>)</p><p id="P58">Abbreviations: ACSM: American College of Sports Medicine; AAPQ: ACSM/American Heart Association Preparticipation Questionnaire; PAR-Q: Physical Activity Readiness Questionnaire; PA: Physical Activity</p></caption><graphic xlink:href="nihms-1557289-f0002"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1:</label><caption><p id="P59">Itemized components of the 2015 ACSM preparticipation screening algorithm and their corresponding items from the National Health and Nutrition Examination Survey, 2001&#x02013;2004.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">ACSM Algorithm Item</th><th colspan="4" align="center" valign="top" rowspan="1">National Health and Nutrition Examination Survey</th></tr><tr style="border-top: solid 1px"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Section</th><th align="left" valign="top" rowspan="1" colspan="1">Variable</th><th align="left" valign="top" rowspan="1" colspan="1">Prompt</th><th align="left" valign="top" rowspan="1" colspan="1">Classification Criteria</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Regular Exercise</bold></td><td align="left" valign="top" rowspan="1" colspan="1">PAQIAF</td><td align="left" valign="top" rowspan="1" colspan="1">PADACTIVE</td><td align="left" valign="top" rowspan="1" colspan="1">Over the past 30 days, what moderate/vigorous activities did you do?</td><td rowspan="5" align="left" valign="top" colspan="1">Reported exercise volume was calculated as: (monthly frequency/4.286)*duration in minutes)*(intensity in metabolic equivalents [METs]). <break/>Those reporting &#x02265;270 MET*minutes/week were classified as currently exercising (30 minutes * 3 times per week * &#x02265;3 METs).</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">PADLEVEL</td><td align="left" valign="top" rowspan="1" colspan="1">Reported intensity level of activity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">PADTIMES</td><td align="left" valign="top" rowspan="1" colspan="1">How many times did you do this activity?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">PADDURAT</td><td align="left" valign="top" rowspan="1" colspan="1">On average, about how long did you do this activity each time?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">PADMETS</td><td align="left" valign="top" rowspan="1" colspan="1">Assigned MET score</td></tr><tr style="border-bottom: solid 1px;border-top: solid 1px"><td align="left" valign="top" rowspan="1" colspan="1"><bold>Disease History</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiovascular disease</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cardiac</td><td align="left" valign="top" rowspan="1" colspan="1">MCQ</td><td align="left" valign="top" rowspan="1" colspan="1">MCQ160E</td><td align="left" valign="top" rowspan="1" colspan="1">Has a doctor or other health professional ever told you that you had a heart attack (aka MI)?</td><td rowspan="2" align="left" valign="top" colspan="1">Those reporting &#x02018;yes&#x02019; to either question were classified as having a history of cardiovascular disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">MCQ</td><td align="left" valign="top" rowspan="1" colspan="1">MCQ160C</td><td align="left" valign="top" rowspan="1" colspan="1">Has a doctor or other health professional ever told you that you had coronary heart disease?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Peripheral vascular</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cerebrovascular</td><td align="left" valign="top" rowspan="1" colspan="1">MCQ</td><td align="left" valign="top" rowspan="1" colspan="1">MCQ160F</td><td align="left" valign="top" rowspan="1" colspan="1">Has a doctor or other health professional ever told you that you had a stroke?</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having a history of cerebrovascular disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Metabolic Disease</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Type I / II Diabetes</td><td align="left" valign="top" rowspan="1" colspan="1">DIQ</td><td align="left" valign="top" rowspan="1" colspan="1">DIQ010</td><td align="left" valign="top" rowspan="1" colspan="1">(Other than during pregnancy) have you ever been told by a doctor or health professional that you have diabetes or sugar diabetes?</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having a history of diabetes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Renal Disease</td><td align="left" valign="top" rowspan="1" colspan="1">KIQ_U</td><td align="left" valign="top" rowspan="1" colspan="1">KIQ022</td><td align="left" valign="top" rowspan="1" colspan="1">Have you ever been told by a doctor or other health professional that you have weak or failing kidneys? Do not include kidney stones, bladder infections, or incontinence.</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having a history of renal disease</td></tr><tr style="border-bottom: solid 1px;border-top: solid 1px"><td align="left" valign="top" rowspan="1" colspan="1"><bold>Signs/Symptoms</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pain/discomfort in chest, neck, jaw, arms, or other areas (ischemia)</td><td align="left" valign="top" rowspan="1" colspan="1">CDQ</td><td align="left" valign="top" rowspan="1" colspan="1">CDQ001</td><td align="left" valign="top" rowspan="1" colspan="1">Have you ever had any pain or discomfort in your chest?</td><td rowspan="3" align="left" valign="top" colspan="1">Those reporting chest pain when walking uphill in a hurry or walking at an ordinary pace on level ground were classified as having pain that might be related to ischemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CDQ002</td><td align="left" valign="top" rowspan="1" colspan="1">Do you get it when you walk up hill or in a hurry? (per 001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">CDQ003</td><td align="left" valign="top" rowspan="1" colspan="1">Do you get it when you walk at an ordinary pace on level ground? (per 001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Shortness of breath at rest or with mild exertion</td><td align="left" valign="top" rowspan="1" colspan="1">CDQ</td><td align="left" valign="top" rowspan="1" colspan="1">CDQ010</td><td align="left" valign="top" rowspan="1" colspan="1">Have you had shortness of breath either when hurrying on the level or walking up a slight hill?</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having shortness of breath with mild exertion</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dizziness or syncope</td><td align="left" valign="top" rowspan="1" colspan="1">BAQ</td><td align="left" valign="top" rowspan="1" colspan="1">BAQ010</td><td align="left" valign="top" rowspan="1" colspan="1">During the past 12 months, have you had dizziness, difficulty with balance, or difficulty with falling?</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having dizziness or syncope</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Orthopnea or PND</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ankle edema</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Palpitations or tachycardia</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intermittent claudication</td><td align="left" valign="top" rowspan="1" colspan="1">DIQ</td><td align="left" valign="top" rowspan="1" colspan="1">DIQ140</td><td align="left" valign="top" rowspan="1" colspan="1">Do you ever get pain in either leg while walking?</td><td align="left" valign="top" rowspan="1" colspan="1">Those reporting &#x02018;yes&#x02019; were classified as having intermittent claudication</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart murmur</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Unusual fatigue</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P60">Abbreviations: MET &#x02013; Metabolic equivalent; PND &#x02013; Paroxysmal nocturnal dyspnea</p></fn><fn id="TFN2"><p id="P61">NHANES section abbreviations: PAQIAF &#x02013; Physical activity individual activities; MCQ &#x02013; Medical conditions; DIQ &#x02013; Diabetes; KIQ_U &#x02013; Kidney conditions, urology; CDQ &#x02013; Cardiovascular health; BAQ - Balance</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2:</label><caption><p id="P62">Percent of respondents aged &#x02265;40 years that would be referred for medical clearance based on the 2015 ACSM preparticipation screening algorithm, National Health and Nutrition Examination Survey, 2001&#x02013;2004</p></caption><table frame="below" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr style="border-bottom: solid 1px"><th align="center" valign="middle" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">No current exercise</th><th colspan="3" align="center" valign="middle" rowspan="1">Yes current exercise</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">No Disease History<break/>No Symptoms</th><th align="center" valign="middle" rowspan="1" colspan="1">Yes Disease History<break/>No Symptoms</th><th align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">Yes Symptoms</th><th align="center" valign="middle" rowspan="1" colspan="1">No Disease History<break/>No Symptoms</th><th align="center" valign="middle" rowspan="1" colspan="1">Yes Disease History<break/>No Symptoms</th><th align="center" valign="middle" rowspan="1" colspan="1">Yes Symptoms</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referral<break/>Status</td><td align="center" valign="middle" rowspan="1" colspan="1">None</td><td align="center" valign="middle" rowspan="1" colspan="1">Before Any</td><td align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">Before Any</td><td align="center" valign="middle" rowspan="1" colspan="1">None</td><td align="center" valign="middle" rowspan="1" colspan="1">Before Vigorous</td><td align="center" valign="middle" rowspan="1" colspan="1">Before Any</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Percent<break/>(95% CI)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.0%<break/>(16.7&#x02013;19.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0%<break/>(2.5&#x02013;3.5)</td><td align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">32.0%<break/>(29.5&#x02013;34.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">25.1%<break/>(22.7&#x02013;27.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.6%<break/>(2.3&#x02013;3.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">19.3%<break/>(18.0&#x02013;20.7)</td></tr><tr style="border-bottom: solid 1px;border-top: solid 1px"><td align="center" valign="middle" rowspan="1" colspan="1"/><td colspan="6" align="center" valign="middle" rowspan="1"><bold>Totals for Each Class of Referral Status</bold></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"/><td colspan="2" align="center" valign="middle" rowspan="1">Not Referred</td><td colspan="2" align="center" valign="middle" rowspan="1">Before Vigorous</td><td colspan="2" align="center" valign="middle" rowspan="1">Before Any</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"/><td colspan="2" align="center" valign="middle" rowspan="1">43.1%<break/>(40.6&#x02013;45.7)</td><td colspan="2" align="center" valign="middle" rowspan="1">2.6%<break/>(2.3&#x02013;3.0)</td><td colspan="2" align="center" valign="middle" rowspan="1">54.2%<break/>(51.6&#x02013;56.8)</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3:</label><caption><p id="P63">Percent of respondents (with 95% confidence interval) aged &#x02265;40 years that would be referred for medical clearance based on the 2015 ACSM preparticipation screening algorithm, stratified by sex and age, National Health and Nutrition Examination Survey, 2001&#x02013;2004</p></caption><table frame="below" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr style="border-bottom: solid 1px"><th align="center" valign="middle" rowspan="1" colspan="1"/><th colspan="7" align="center" valign="middle" rowspan="1">Age Categories (Years)</th><th align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">40&#x02013;44</th><th align="center" valign="middle" rowspan="1" colspan="1">45&#x02013;49</th><th align="center" valign="middle" rowspan="1" colspan="1">50&#x02013;54</th><th align="center" valign="middle" rowspan="1" colspan="1">55&#x02013;59</th><th align="center" valign="middle" rowspan="1" colspan="1">60&#x02013;64</th><th align="center" valign="middle" rowspan="1" colspan="1">65&#x02013;69</th><th align="center" valign="middle" rowspan="1" colspan="1">70+</th><th align="center" valign="middle" rowspan="1" colspan="1">Overall</th></tr><tr style="border-bottom: solid 1px"><th align="center" valign="middle" rowspan="1" colspan="1">WOMEN</th><th align="center" valign="middle" rowspan="1" colspan="1">n=447</th><th align="center" valign="middle" rowspan="1" colspan="1">n=394</th><th align="center" valign="middle" rowspan="1" colspan="1">n=370</th><th align="center" valign="middle" rowspan="1" colspan="1">n=268</th><th align="center" valign="middle" rowspan="1" colspan="1">n=420</th><th align="center" valign="middle" rowspan="1" colspan="1">n=348</th><th align="center" valign="middle" rowspan="1" colspan="1">n=1138</th><th align="center" valign="middle" rowspan="1" colspan="1">n=3385</th></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred Vigorous</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2%<break/>(0.4&#x02013;3.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5%<break/>(0.6&#x02013;3.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1%<break/>(0.9&#x02013;4.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0%<break/>(0.7&#x02013;5.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2%<break/>(1.7&#x02013;5.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0%<break/>(1.3&#x02013;6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.8%</bold><break/>(1.1&#x02013;2.9)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.9%</bold><break/>(1.5&#x02013;2.5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred Any</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>49.8%</bold><break/>(42.4&#x02013;57.2)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>51.9%</bold><break/>(45.9&#x02013;58.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">56.1%<break/>(47.7&#x02013;64.2)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>61.9%</bold><break/>(55.1&#x02013;68.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">57.9%<break/>(50.1&#x02013;65.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">66.3%<break/>(59.8&#x02013;72.2)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>74.6%</bold><break/>(71.2&#x02013;77.7)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>59.8%</bold><break/>(56.3&#x02013;63.2)</td></tr></tbody><tbody><tr style="border-bottom: solid 1px"><th align="center" valign="middle" rowspan="1" colspan="1">MEN</th><th align="center" valign="middle" rowspan="1" colspan="1">n=447</th><th align="center" valign="middle" rowspan="1" colspan="1">n=406</th><th align="center" valign="middle" rowspan="1" colspan="1">n=386</th><th align="center" valign="middle" rowspan="1" colspan="1">n=261</th><th align="center" valign="middle" rowspan="1" colspan="1">n=384</th><th align="center" valign="middle" rowspan="1" colspan="1">n=341</th><th align="center" valign="middle" rowspan="1" colspan="1">n=1051</th><th align="center" valign="middle" rowspan="1" colspan="1">n=3276</th></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred Vigorous</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5%<break/>(1.1&#x02013;5.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2%<break/>(1.3&#x02013;3.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.1%<break/>(1.6&#x02013;5.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0%<break/>(0.7&#x02013;5.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9%<break/>(21.&#x02212;7.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.0%<break/>(4.2&#x02013;11.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5%<break/>(3.9&#x02013;7.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4%<break/>(3.0&#x02013;4.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred Any</td><td align="center" valign="middle" rowspan="1" colspan="1">36.1%<break/>(31.3&#x02013;41.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">34.4%<break/>(30.8&#x02013;38.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">50.8%<break/>(46.0&#x02013;55.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">49.1%<break/>(42.4&#x02013;55.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">57.0%<break/>(48.6&#x02013;65.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">57.1%<break/>(48.6&#x02013;65.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">65.7%<break/>(62.3&#x02013;68.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">48.1%<break/>(45.7&#x02013;50.5)</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P64">Values for women in bold are significantly different than the comparable value among men (Bonferroni-adjusted p&#x0003c;0.05)</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4:</label><caption><p id="P65">Cross-tabulation of the percent of respondents (with 95% confidence interval) aged &#x02265;40 years that would be referred for medical clearance by three screening tools, National Health and Nutrition Examination Survey, 2001&#x02013;2004</p></caption><table frame="below" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="bottom" style="border-bottom: solid 1px;border-right: solid 1px" rowspan="1">AAPQ Referral Status</th><th colspan="2" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">PAR-Q Referral Status</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">ACSM Algorithm Referral Status</th><th align="center" valign="bottom" rowspan="1" colspan="1">Not Referred</th><th align="center" valign="bottom" style="border-right: solid 1px" rowspan="1" colspan="1">Referred</th><th align="center" valign="bottom" rowspan="1" colspan="1">Not Referred</th><th align="center" valign="bottom" rowspan="1" colspan="1">Referred</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Not Referred</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5%<break/>(4.6&#x02013;6.5)</td><td align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">37.7%<break/>(35.3&#x02013;40.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.1%<break/>(22.4&#x02013;25.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">19.0%<break/>(17.5&#x02013;20.7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred-Vigorous</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.1%<break/>(&#x0003c;0.1&#x02013;0.1)</td><td align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">2.6%<break/>(2.3&#x02013;3.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5%<break/>(0.4&#x02013;0.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1%<break/>(1.8&#x02013;2.5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Referred-Any</td><td align="center" valign="middle" rowspan="1" colspan="1">0%</td><td align="center" valign="middle" style="border-right: solid 1px" rowspan="1" colspan="1">54.2%<break/>(51.7&#x02013;56.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.9%<break/>(6.2&#x02013;7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">47.3%<break/>(44.5&#x02013;50.1)</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P66">ACSM: American College of Sports Medicine</p></fn><fn id="TFN5"><p id="P67">AAPQ: ACSM/American Heart Association Preparticipation Questionnaire</p></fn><fn id="TFN6"><p id="P68">PAR-Q: Physical Activity Readiness Questionnaire</p></fn></table-wrap-foot></table-wrap></floats-group></article>